market exclusivity

Study: Patent Term Restoration Extends Drug Patents by About 3 Years
Study: Patent Term Restoration Extends Drug Patents by About 3 Years
RAPS.org
patents
patent term restoration
market exclusivity
Flag link:
FDA ups the ante for copycats, antibiotics, orphan drugs. But is it working?
FDA ups the ante for copycats, antibiotics, orphan drugs. But is it working?
Biopharma Dive
FDA
generics
competition
market exclusivity
Flag link:
Market Exclusivity is not What Attracts Orphan Drug Investment, Research Finds
Market Exclusivity is not What Attracts Orphan Drug Investment, Research Finds
RAPS.org
market exclusivity
orphan drugs
Flag link:
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Xtalks
generics
FDA
FTC
market exclusivity
Flag link:
Amarin - Vascepa Gains Protection Until At Least 2020
Amarin - Vascepa Gains Protection Until At Least 2020
Seeking Alpha
Amarin
Vascepa
FDA
market exclusivity
Flag link:
FDA Grants Fanapt® Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia
FDA Grants Fanapt® Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia
Yahoo
FDA
Fanapt
Vanda Pharmaceuticals
market exclusivity
schizophrenia
Flag link:
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Pharmalot
Eisai
Fycompa
Belviq
FDA
DEA
market exclusivity
Flag link:
Bill is Introduced to Provide Added Exclusivity for Fixed-Dose Drugs
Bill is Introduced to Provide Added Exclusivity for Fixed-Dose Drugs
WSJ Pharmalot
fixed-dose
market exclusivity
Flag link:
Senators Call for 15 Years of Marketing Exclusivity for Some New Drugs
Senators Call for 15 Years of Marketing Exclusivity for Some New Drugs
RAPS.org
market exclusivity
patents
Flag link:
Arena Pharma Denied Request Added Market Exclusivity for Weight-Loss Drug
Arena Pharma Denied Request Added Market Exclusivity for Weight-Loss Drug
TheStreet.com
Arena Pharmaceuticals
market exclusivity
FDA
Eisai
Belviq
Flag link: